Medicamen Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 926.91 million compared to INR 914.77 million a year ago. Revenue was INR 940.74 million compared to INR 916.94 million a year ago. Net income was INR 121.52 million compared to INR 84.83 million a year ago. Basic earnings per share from continuing operations was INR 9.95 compared to INR 6.94 a year ago. Diluted earnings per share from continuing operations was INR 9.95 compared to INR 6.94 a year ago.